Kolexia
Goardon Nicolas Médecine générale
Goardon Nicolas
Médecine générale
Centre François-Baclesse
Caen, France
46 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Tumeurs de l'ovaire Leucémie aigüe myéloïde Carcinomes Leucémie myéloïde Prédisposition génétique à une maladie Carcinome épidermoïde Carcinome hépatocellulaire Maladies de la thyroïde

Collaborateurs

Voir plus
Vaur Dominique
Vaur Dominique
Centre François-Baclesse, Caen, France
Castera Laurent
Castera Laurent
Centre François-Baclesse, Caen, France
Krieger Sophie
Krieger Sophie
Centre François-Baclesse, Caen, France
Muller Etienne
Muller Etienne
Centre François-Baclesse, Caen, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Therapeutic advances in urology   28 février 2024
OLA-TMZ-RTE-01: Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
Essai Clinique (Centre François-Baclesse)   02 janvier 2024
DrugOrder: an automated method for ranking variant/drug associations using large panel of cancer genes
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
ORGAVADS: Establishment of Squamous Cell Organoids of the Head and Neck to Assess Their Response to Innovative Therapies
Essai Clinique (Centre François-Baclesse)   24 novembre 2023
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research   02 novembre 2023
TALASUR: TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma: A Single-arm Phase 2 Trial
Essai Clinique (Pfizer)   31 juillet 2023
Short and long read targeted RNAseq approaches to detect complex abnormalities for cancer susceptibility genes
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference   01 mai 2023
Development of genomic instability score for ovarian cancers from a limited panel of genes
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference   01 mai 2023
ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.
BMC cancer   09 mars 2023
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.
BMC cancer   24 novembre 2022